SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-24-001482
Filing Date
2024-09-25
Accepted
2024-09-25 16:12:21
Documents
16
Period of Report
2024-09-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e5980_8-k.htm   iXBRL 8-K 29473
2 EXHIBIT 16.1 e5980_ex16-1.htm EX-16.1 2701
3 EXHIBIT 17.1 e5980_ex17-1.htm EX-17.1 6203
4 GRAPHIC image_003.jpg GRAPHIC 10902
  Complete submission text file 0001731122-24-001482.txt   235669

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vrpx-20240920.xsd EX-101.SCH 3027
6 XBRL LABEL FILE vrpx-20240920_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE vrpx-20240920_pre.xml EX-101.PRE 24173
18 EXTRACTED XBRL INSTANCE DOCUMENT e5980_8-k_htm.xml XML 3806
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 241324200
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)